Company intelligence / Profile preview
TransMolecular
Birmingham, Alabama, United Statestransmolecular.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TransMolecular was a biotechnology company focused on developing novel drugs for cancer treatment, particularly targeting disorders of the central nervous system. Their pipeline included TM-604 for neoplasms and chlorotoxin-based therapies for glioblastoma multiforme.
- Therapeutic areas
- Oncology
- Modalities
- Synthetic peptide
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on TransMolecular.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TransMolecular.